Share: 
Status: 
Active
Rating: 
No votes yet
0

On Demand 2016 Practice Essentials: Immunotherapy and Practice Management

Course description

This package is a collection of the presentations from Thursday's Practice Essentials program.

Credits/pricing
5.25 AMA PRA Category 1 Credit(s)TM
$105 College members, $159 non-members

Release Date: 12/01/2016
Expiration Date: 11/30/2019

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 5.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Learning objectives: 
  • Discuss the early concepts of immunotherapy and how what we currently do was based on the research of Noon
  • Review current indications for subcutaneous and sublingual immunotherapy and best practice of allergen immunotherapy
  • Discuss prospective innovations in allergy immunotherapy
  • Describe the proper coding for appropriate billing to optimize reimbursement
  • Discuss the new payment models and understand how other regulatory changes are impacting allergy practice
  • Interpret allergy-specific compensation and production data (RVUs)
  • Analyze allergists’ beliefs on fairness in compensation and career satisfaction
  • Critique allergists’ productivity in the workplace
Credits
  • 5.25 AMA PRA Category 1 Credit™
  • 5.25 Attendance
Additional information
Disclosure: 

John J. Oppenheimer, MD, FACAAI, Moderator -- Consultant/Advisor: AstraZeneca, Genentech, GlaxoSmithKline, Meda, Mylan, Novartis, Annals of Allergy, ABAI, Up to date, Teva; Supported/ Contracted Research: AstraZeneca, Genentech, MedImmune, Sanofi

Harold S. Nelson, MD, FACAAI -- Consultant/Advisor: AstraZeneca, Circassia, Merck; Supported/Contracted Research: Circassia

Jonathan Corren, MD -- Supported/Contracted Research: Amgen

Mark Larche, PhD -- Consultant/Advisor: AbbVie, Circassia, Aravax Pty, UCB, Adiga Life Sciences Inc; Supported/Contracted Research: Circassia, Adiga Life Sciences Inc; Patent Holder/Royalty/IPR: Circassia; Ownership Interest: Circassia

Stephen R. Durham, MD -- Consultant/Advisor: Boehringer Ingelheim, Circassia, Merck, Biomay, Anergis; Speaker: ALK, PneumoUpdate Gmbh; Supported/Contracted Research: ALK, Merck, Regeneron

Stanley M. Fineman, MD, MBA, FACAAI, Moderator -- Consultant/Advisor: Aimmune; Speaker: AstraZeneca, Boehringer Ingelheim, Genentech, Greer, Meda, Novartis, Nestle, Teva; Supported/Contracted Research: DBV Technologies, Genentech, Greer, Meda, Aimmune, Stallergenes

J. Allen Meadows, MD, FACAAI -- Speaker: Meda

James M. Tracy, DO, FACAAI -- Consultant/Advisor: Shire; Speaker: UptoDate

Michael S. Blaiss, MD, FACAAI -- Consultant/Advisor: Response Scientific, JDP Therapeutics, Pfizer; Ownership Interest: AllergyZone, Response Scientific, JDP Therapeutics

The following have no financial relationship to disclose:

Kari C. Nadeau, MD, PhD

Kay Tyler, BS, BA, MBA

Gary N. Gross, MD, FACAAI

This activity is supported by independent educational grants from the following commercial supporters:

AstraZeneca Partial support of Workshop W24 on Managing Severe Asthma in Adults and Children.

Boston Scientific Supporter of the Virtual Roundtable on Advancing Management of Severe Asthma: A Review of Available Evidence to Guide Current Treatment.

CSL Behring Supporter of the Friday Symposium on Diagnosis and Treatment of Primary Immune Deficiency.

Dormer Laboratories Inc. In-kind support consisting of loaned durable equipment for Workshop W6 on Office Procedures for Allergic Skin Diseases.

GlaxoSmithKline Supporter of the Sunday Symposium on What to Do When Asthma Does Not Respond to Step 3 Treatment…and partial support of Workshop W24 on Managing Severe Asthma in Adults and Children.

Karl Storz Endoscopy-America, Inc. In-kind support consisting of loaned durable equipment for Workshops W12, W15 and W17 – Hands-On Session in Rhinolaryngoscopy.

Meda Pharmaceuticals, Inc. Supporter of the Monday Plenary Session on Asthma in 2016: Advances in Understanding Origin, Presentation and Approaches to Management.

Micro Direct, Inc. In-kind support consisting of loaned durable equipment for Workshops AHP3 and AHP6 Nuts and Bolts of Spirometry Interpretation.

Mylan Specialty L.P. Supporter of the Friday Breakfast Symposium on Leading the Pack: Allergists as Anaphylaxis Experts.

Nestlé Nutrition Institute Supporter of Workshop W11 on Food Allergies: What’s New in Prevention and Treatment.

Regeneron Pharmaceuticals/ Sanofi Genzyme Partial support of the Monday Plenary Session on Modern Therapies for Allergic Skin Diseases.

Salix Pharmaceuticals Partial support of the Friday Luncheon Symposium on Early Recognition and Effective Management of Hereditary Angioedema…and a video session of the symposium.

Shire Partial support of the Friday Luncheon Symposium on Early Recognition and Effective Management of Hereditary Angioedema…and the Sunday Symposium on Immunoglobulin Replacement for the Allergist: Update on Guidelines.

SmartPractice In-kind support consisting of loaned durable equipment for Workshop W6 on Office Procedures for Allergic Skin Diseases.

Teva Respiratory Supporter of the Friday Symposium on The Use of Biologics in Severe Asthma.

Course summary
Available credit: 
  • 5.25 AMA PRA Category 1 Credit™
  • 5.25 Attendance
Course opens: 
11/12/2016
Course expires: 
11/30/2019
Cost:
$159.00
Please login or create an account to take this course.

Payment required

You must purchase this course.